Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation

ClinicalTrials.gov ID: NCT00953706

Public ClinicalTrials.gov record NCT00953706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 5:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of VX-770 in Subjects Aged 12 Years and Older With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

Study identification

NCT ID
NCT00953706
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vertex Pharmaceuticals Incorporated
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

  • Ivacaftor Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2009
Primary completion
Jun 30, 2010
Completion
Apr 30, 2013
Last update posted
Sep 10, 2015

2009 – 2013

United States locations

U.S. sites
34
U.S. states
24
U.S. cities
33
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35294
Providence Medical Center Anchorage Alaska 99508
Kaiser Permanente Medical Care Program Oakland California 94611
Connecticut Children's Medical Center Hartford Connecticut 06106
University of Miami Miller School of Medicine Miami Florida 33136
Nemours Children's Clinic Orlando Florida 32801
St. Luke's CF clinic Boise Idaho 83712
University of Chicago Chicago Illinois 60637
Riley Hospital for Children Indianapolis Indiana 46202
Maine Medical Center Portland Maine 04102
Massachusetts General Hospital Boston Massachusetts 02114
University of Massachussetts Medical School Worcester Massachusetts 01655
Helen DeVos Children's Hospital; Spectrum Health Hospitals Grand Rapids Michigan 49503
The Children's Mercy Hospital Kansas City Missouri 64108
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Monmouth Medical Center Long Branch New Jersey 07740
Morristown Memorial Hospital Morristown New Jersey 07962
Albany Medical College Albany New York 12208
Women and Children's Hospital of Buffalo Buffalo New York 14222
New York Medical College Hawthorne New York 10532
The CF Center, Beth Israel Medical Center New York New York 10003
Columbia University Medical Center New York New York 10032
Akron Children's Hospital Akron Ohio 44308
Cincinnati Children's Hospital Cincinnati Ohio 45229
Toldedo Children's Hospital Toledo Ohio 43606
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Hershey Medical Center Hershey Pennsylvania 17033
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134
Medical University of South Carolina Charleston South Carolina 29425
University of Tennessee Memphis Tennessee 38103
Cook Children's Medical Center Fort Worth Texas 76104
Univeristy of Utah Salt Lake City Utah 84132
Vermont Lung Center at the University of Vermont Colchester Vermont 05446
Medical College of Virginia Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00953706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2015 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00953706 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →